ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 177 filers reported holding ARGENX SE in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $529,978 | +38.9% | 1,078 | +10.1% | 0.05% | +39.5% |
| Q2 2023 | $381,546 | +13.2% | 979 | +8.2% | 0.04% | +8.6% |
| Q1 2023 | $337,185 | -10.1% | 905 | -8.6% | 0.04% | -18.6% |
| Q4 2022 | $375,042 | -8.1% | 990 | -14.4% | 0.04% | -20.4% |
| Q3 2022 | $408,000 | +22.2% | 1,157 | +31.3% | 0.05% | +20.0% |
| Q2 2022 | $334,000 | +78.6% | 881 | +48.3% | 0.04% | +95.7% |
| Q1 2022 | $187,000 | +13.3% | 594 | +26.1% | 0.02% | +15.0% |
| Q4 2021 | $165,000 | +39.8% | 471 | +20.2% | 0.02% | +25.0% |
| Q3 2021 | $118,000 | +12.4% | 392 | +12.6% | 0.02% | +6.7% |
| Q2 2021 | $105,000 | +23.5% | 348 | +12.6% | 0.02% | +7.1% |
| Q1 2021 | $85,000 | +28.8% | 309 | +38.6% | 0.01% | +16.7% |
| Q4 2020 | $66,000 | +73.7% | 223 | +54.9% | 0.01% | +50.0% |
| Q3 2020 | $38,000 | +1800.0% | 144 | +1340.0% | 0.01% | – |
| Q2 2020 | $2,000 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 49,950 | $14,690,000 | 5.25% |
| Avoro Capital Advisors LLC | 902,500 | $265,416,000 | 4.57% |
| Eagle Health Investments LP | 19,587 | $5,760,000 | 3.68% |
| Redmile Group, LLC | 918,307 | $270,065,000 | 3.27% |
| Bellevue Group AG | 945,348 | $278,018,000 | 3.18% |
| AWM Investment Company, Inc. | 80,000 | $23,527,000 | 2.99% |
| DCF Advisers, LLC | 24,000 | $7,058,000 | 2.91% |
| Ikarian Capital, LLC | 201,500 | $59,260,000 | 2.61% |
| JGP Global Gestao de Recursos Ltda. | 1,859 | $547,000 | 2.06% |
| Evolutionary Tree Capital Management, LLC | 8,798 | $2,587,000 | 1.97% |